BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/17/2022 3:19:26 AM | Browse: 764 | Download: 2366
 |
Received |
|
2021-10-10 10:25 |
|
Peer-Review Started |
|
2021-10-10 10:27 |
|
First Decision by Editorial Office Director |
|
2021-12-10 02:28 |
|
Return for Revision |
|
2021-12-10 02:28 |
|
Revised |
|
2021-12-24 15:32 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-04-29 03:12 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-04-30 07:39 |
|
Articles in Press |
|
2022-04-30 07:39 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-05-31 02:27 |
|
Publish the Manuscript Online |
|
2022-06-17 03:19 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Immunology |
| Manuscript Type |
Case Report |
| Article Title |
Pembrolizumab-induced Stevens-Johnson syndrome in advanced squamous cell carcinoma of the lung: A case report and review of literature
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jing-Yi Wu, Kai Kang, Jing Yi and Bin Yang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Bin Yang, MS, Academic Fellow, Academic Research, Additional Professor, Department of Thoracic Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Techonology, No.116 Zhuo Daoquan South Road, Wuhan 430000, Hubei Province, China. dlhdr2011@163.com |
| Key Words |
Pembrolizumab; Stevens-Johnson syndrome; Advanced squamous cell carcinoma; Lung; Immune-related adverse events; Case report |
| Core Tip |
Stevens-Johnson syndrome (SJS) is a rare but extremely severe cutaneous adverse drug reaction with high mortality. The case involved a 68-year-old female who was diagnosed with advanced squamous cell carcinoma of the lung. SJS syndrome appeared after one cycle of immunotherapy. After the optimal supportive treatment, skin toxicity disappeared. |
| Publish Date |
2022-06-17 03:19 |
| Citation |
Wu JY, Kang K, Yi J, Yang B. Pembrolizumab-induced Stevens-Johnson syndrome in advanced squamous cell carcinoma of the lung: A case report and review of literature. World J Clin Cases 2022; 10(18): 6110-6118
|
| URL |
https://www.wjgnet.com/2307-8960/full/v10/i18/6110.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v10.i18.6110 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
